Drug Repurposing: An Alternative Strategy to Treat COVID-19

被引：0
|
作者：
Han, Pengyu [1 ,2 ]
Zheng, Huifang [1 ]
Wen, Pingping [3 ]
Pan, Li [3 ]
Geng, Dan [3 ]
Sun, Dianxing [1 ]
机构：
[1] 980th Hosp PLA Joint Logist Force, Dept Infect Dis, Shijiazhuang 050082, Hebei, Peoples R China
[2] Dandong Customs House, Dandong, Peoples R China
[3] Dept Technol, Dalian, Peoples R China
来源：
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2022年 / 23卷 / 06期
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; immuno-regulation; risk factor; pH; Anti-viral agents; surfactants; PROLIFERATOR-ACTIVATED RECEPTORS; N-ACETYL-CYSTEINE; INSULIN-RESISTANCE; HOST-DEFENSE; ZINC IONS; SARS-COV; T-CELLS; VIRUS; INFLAMMATION; DIETHYLCARBAMAZINE;
D O I：
10.2174/1389201022666210709141320
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Compared to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other wellknown diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible strategies of drug repurposing in the treatment of COVID-19 and explored the possible scientific mechanisms behind each strategy.
引用
收藏
页码：818 / 827
页数：10
相关论文
共 50 条
  • [41] Drug repurposing: new strategies for addressing COVID-19 outbreak
    Shende, Pravin
    Khanolkar, Bhakti
    Gaud, R. S.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (06) : 689 - 706
  • [42] Can drug repurposing strategies be the solution to the COVID-19 crisis?
    Bellera, Carolina L.
    Llanos, Manuel
    Gantner, Melisa E.
    Rodriguez, Santiago
    Gavernet, Luciana
    Comini, Marcelo
    Talevi, Alan
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (06) : 605 - 612
  • [43] DEEP LEARNING TO DRIVE COVID-19 RAPID DRUG REPURPOSING
    Kolitz, Sarah
    Kim, Jason
    Zhang, Jenny
    Cha, Yoonjeong
    Battula, Sailaja
    Kusko, Rebecca
    Krishnan, Rajaraman
    Zeskind, Benjamin
    Kaufman, Howard
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A293 - A293
  • [44] Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
    Mahmoud, Dina B.
    Shitu, Zayyanu
    Mostafa, Ahmed
    [J]. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2020, 18 (01)
  • [45] Drug repurposing for COVID-19: Approaches, challenges and promising candidates
    Ng, Yan Ling
    Salim, Cyrill Kafi
    Chu, Justin Jang Hann
    [J]. PHARMACOLOGY & THERAPEUTICS, 2021, 228
  • [46] Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
    Dina B. Mahmoud
    Zayyanu Shitu
    Ahmed Mostafa
    [J]. Journal of Genetic Engineering and Biotechnology, 18
  • [47] Psychedelics and Mental Health: An Alternative Strategy to Treat Mental Impairments Triggered or Aggravated by COVID-19
    Bruno, Vitor
    Wiazowski Spelta, Lidia Emmanuela
    Durao, Ana Carolina
    Camarini, Rosana
    Marcourakis, Tania
    [J]. ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2022, 28 (04) : 40 - 43
  • [48] A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19
    Khurana, Pankaj
    Varshney, Rajeev
    Gupta, Apoorv
    [J]. HELIYON, 2022, 8 (05)
  • [49] Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy
    Kumar, Muthu T.
    Rohini, K.
    James, Nivya
    Shanthi, V
    Ramanathan, K.
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2021, 68 (04) : 712 - 725
  • [50] DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing
    Bejan, Cosmin A.
    Cahill, Katherine N.
    Staso, Patrick J.
    Choi, Leena
    Peterson, Josh F.
    Phillips, Elizabeth J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1537 - 1546
12345